[1]
|
Boesen, M.S., Blinkenberg, M., Koch-Henriksen, N., Thygesen, L.C., Uldall, P.V., Magyari, M., et al. (2018) Implications of the International Paediatric Multiple Sclerosis Study Group Consensus Criteria for Paediatric Acute Disseminated Encephalomyelitis: A Nationwide Validation Study. Developmental Medicine and Child Neurology, 60, 1123-1131. https://doi.org/10.1111/dmcn.13798
|
[2]
|
Leake, J.A., Albani, S., Kao, A.S., Senac, M.O., Billman, G.F., Nespeca, M.P., et al. (2004) Acute Disseminated Encephalomyelitis in Childhood: Epidemiologic, Clinical and Laboratory Features. The Pediatric Infectious Disease Journal, 23, 756-764. https://doi.org/10.1097/01.inf.0000133048.75452.dd
|
[3]
|
Torisu, H., Kira, R., Ishizaki, Y., Sanefuji, M., Yamaguchi, Y., Yasumoto, S., et al. (2010) Clinical Study of Childhood Acute Disseminated Encephalomyelitis, Multiple Sclerosis, and Acute Transverse Myelitis in Fukuoka Prefecture, Japan. Brain & Development, 32, 454-462. https://doi.org/10.1016/j.braindev.2009.10.006
|
[4]
|
Schwarz, S., Mohr, A., Knauth, M., Wildemann, B. and Storch-Hagenlocher, B. (2001) Acute Disseminated Encephalomyelitis: A Follow-up Study of 40 Adult Patients. Neurology, 56, 1313-1318.
https://doi.org/10.1212/WNL.56.10.1313
|
[5]
|
Mikaeloff, Y., Caridade, G., Husson, B., Suissa, S. and Tardieu, M. (2007) Acute Disseminated Encephalomyelitis Cohort Study: Prognostic Factors for Relapse. European Journal of Paediatric Neurology, 11, 90-95.
https://doi.org/10.1016/j.ejpn.2006.11.007
|
[6]
|
Koelman, D.L., Chahin, S., Mar, S.S., Venkatesan, A., Hoganson, G.M., Yeshokumar, A.K., et al. (2016) Acute Disseminated Encephalomyelitis in 228 Patients: A Retrospective, Multicenter US Study. Neurology, 86, 2085-2093.
https://doi.org/10.1212/WNL.0000000000002723
|
[7]
|
Cole, J., Evans, E., Mwangi, M. and Mar, S. (2019) Acute Disseminated Encephalomyelitis in Children: An Updated Review Based on Current Diagnostic Criteria. Pediatric Neurology, 100, 26-34.
https://doi.org/10.1016/j.pediatrneurol.2019.06.017
|
[8]
|
Ketelslegers, I.A., Visser, I.E., Neuteboom, R.F., Boon, M., Catsman-Berrevoets, C.E. and Hintzen, R.Q. (2011) Disease Course and Outcome of Acute Disseminated Encephalomyelitis Is More Severe in Adults than in Children. Multiple Sclerosis Journal, 17, 441-448. https://doi.org/10.1177/1352458510390068
|
[9]
|
Brenton, J.N. and Banwell, B.L. (2016) Therapeutic Approach to the Management of Pediatric Demyelinating Disease: Multiple Sclerosis and Acute Disseminated Encephalomyelitis. Neurotherapeutics, 13, 84-95.
https://doi.org/10.1007/s13311-015-0396-0
|
[10]
|
Jarousse, N., Viktorova, E.G., Pilipenko, E.V., Agol, V.I. and Brahic, M. (1999) An Attenuated Variant of the GDVII Strain of Theiler’s Virus Does Not Persist and Does Not Infect the White Matter of the Central Nervous System. Journal of Virology, 73, 801-804. https://doi.org/10.1128/JVI.73.1.801-804.1999
|
[11]
|
Wong, Y.Y.M., Hacohen, Y., Armangue, T., Wassmer, E., Verhelst, H., Hemingway, C., et al. (2018) Paediatric Acute Disseminated Encephalomyelitis Followed by Optic Neuritis: Disease Course, Treatment Response and Outcome. European Journal of Neurology, 25, 782-786. https://doi.org/10.1111/ene.13602
|
[12]
|
Chen, Y., Ma, F., Xu, Y., Chu, X. and Zhang, J. (2018) Vaccines and the Risk of Acute Disseminated Encephalomyelitis. Vaccine, 36, 3733-3739. https://doi.org/10.1016/j.vaccine.2018.05.063
|
[13]
|
Reindl, M., Di Pauli, F., Rostásy, K. and Berger, T. (2013) The Spectrum of MOG Autoantibody-Associated Demyelinating Diseases. Nature Reviews Neurology, 9, 455-461. https://doi.org/10.1038/nrneurol.2013.118
|
[14]
|
Waters, P., Woodhall, M., O’Connor, K.C., Reindl, M., Lang, B., Sato, D.K., et al. (2015) MOG Cell-Based Assay Detects Non-MS Patients with Inflammatory Neurologic Disease. Neurology(R) Neuroimmunology & Neuroinflammation, 2, Article No. e89. https://doi.org/10.1212/NXI.0000000000000089
|
[15]
|
Jarius, S., Paul, F., Aktas, O., Asgari, N., Dale, R.C., de Seze, J., et al. (2018) MOG Encephalomyelitis: International Recommendations on Diagnosis and Antibody Testing. Journal of Neuroinflammation, 15, Article No. 134.
https://doi.org/10.1186/s12974-018-1144-2
|
[16]
|
Bruijstens, A.L., Lechner, C., Flet-Berliac, L., Deiva, K., Neuteboom, R.F., Hemingway, C., et al. (2020) E.U. Paediatric MOG Consortium Consensus: Part 1—Classification of Clinical Phenotypes of Paediatric Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disorders. European Journal of Paediatric Neurology, 29, 2-13.
https://doi.org/10.1016/j.ejpn.2020.10.006
|
[17]
|
Krupp, L.B., Tardieu, M., Amato, M.P., Banwell, B., Chitnis, T., Dale, R.C., et al. (2013) International Pediatric Multiple Sclerosis Study Group Criteria for Pediatric Multiple Sclerosis and Immune-Mediated Central Nervous System Demyelinating Disorders: Revisions to the 2007 Definitions. Multiple Sclerosis Journal, 19, 1261-1267.
https://doi.org/10.1177/1352458513484547
|
[18]
|
Baumann, M., Sahin, K., Lechner, C., Hennes, E.M., Schanda, K., Mader, S., et al. (2015) Clinical and Neuroradiological Differences of Paediatric Acute Disseminating Encephalomyelitis with and without Antibodies to the Myelin Oligodendrocyte Glycoprotein. Journal of Neurology, Neurosurgery, and Psychiatry, 86, 265-272.
https://doi.org/10.1136/jnnp-2014-308346
|
[19]
|
Zhang, M., Shen, J., Zhou, S., Du, X., Li, W., Yu, L., et al. (2020) Clinical and Neuroimaging Characteristics of Pediatric Acute Disseminating Encephalomyelitis with and without Antibodies to Myelin Oligodendrocyte Glycoprotein. Frontiers in Neurology, 11, Article ID: 593287. https://doi.org/10.3389/fneur.2020.593287
|
[20]
|
Hung, P.C., Wang, H.S., Chou, M.L., Lin, K.L., Hsieh, M.Y. and Wong, A.M. (2012) Acute Disseminated Encephalomyelitis in Children: A Single Institution Experience of 28 Patients. Neuropediatrics, 43, 64-71.
https://doi.org/10.1055/s-0032-1309309
|
[21]
|
Baumann, M., Grams, A., Djurdjevic, T., Wendel, E.M., Lechner, C. and Behring, B., et al. (2018) MRI of the First Event in Pediatric Acquired Demyelinating Syndromes with Antibodies to Myelin Oligodendrocyte Glycoprotein. Journal of Neurology, 265, 845-855. https://doi.org/10.1007/s00415-018-8781-3
|
[22]
|
Alexander, M. and Murthy, J.M. (2011) Acute Disseminated Encephalomyelitis: Treatment Guidelines. Annals of Indian Academy of Neurology, 14, S60-A64. https://doi.org/10.4103/0972-2327.83095
|
[23]
|
Shahar, E., Andraus, J., Savitzki, D., Pilar, G. and Zelnik, N. (2002) Outcome of Severe Encephalomyelitis in Children: Effect of High-Dose Methylprednisolone and Immunoglobulins. Journal of Child Neurology, 17, 810-814.
https://doi.org/10.1177/08830738020170111001
|
[24]
|
Pohl, D., Alper, G., Van Haren, K., Kornberg, A.J., Lucchinetti, C.F., Tenembaum, S., et al. (2016) Acute Disseminated Encephalomyelitis: Updates on an Inflammatory CNS Syndrome. Neurology, 87, S38-S45.
https://doi.org/10.1212/WNL.0000000000002825
|
[25]
|
Anlar, B., Basaran, C., Kose, G., et al. (2003) Acute Disseminated Encephalomyelitis in Children: Outcome and Prognosis. Neuropediatrics, 34, 194-199. https://doi.org/10.1055/s-2003-42208
|
[26]
|
Cobo-Calvo, A., Ruiz, A., Maillart, E., Audoin, B., Zephir, H., Bourre, B., et al. (2018) Clinical Spectrum and Prognostic Value of CNS MOG Autoimmunity in Adults: The MOGADOR Study. Neurology, 90, e1858-e1869.
https://doi.org/10.1212/WNL.0000000000005560
|
[27]
|
Jurynczyk, M., Messina, S., Woodhall, M.R., Raza, N., Everett, R., Roca-Fernandez, A., et al. (2017) Clinical Presentation and Prognosis in MOG-Antibody Disease: A UK Study. Brain, 140, 3128-3138.
https://doi.org/10.1093/brain/awx276
|
[28]
|
Reindl, M. and Waters, P. (2019) Myelin Oligodendrocyte Glycoprotein Antibodies in Neurological Disease. Nature Reviews Neurology, 15, 89-102. https://doi.org/10.1038/s41582-018-0112-x
|
[29]
|
Otallah, S. (2020) Acute Disseminated Encephalomyelitis in Children and Adults: A Focused Review Emphasizing New Developments. Multiple Sclerosis Journal, 27, 1153-1160. https://doi.org/10.1177/1352458520929627
|
[30]
|
Hacohen, Y., Absoud, M., Deiva, K., Hemingway, C., Nytrova, P., Woodhall, M., et al. (2015) Myelin Oligodendrocyte Glycoprotein Antibodies Are Associated with a Non-MS Course in Children. Neurology(R) Neuroimmunology & Neuroinflammation, 2, Article No. e81. https://doi.org/10.1212/NXI.0000000000000081
|
[31]
|
Cobo-Calvo, A., Sepúlveda, M., Rollot, F., Armangué, T., Ruiz, A., Maillart, E., et al. (2019) Evaluation of Treatment Response in Adults with Relapsing MOG-Ab-Associated Disease. Journal of Neuroinflammation, 16, Article No. 134.
https://doi.org/10.1186/s12974-019-1525-1
|
[32]
|
Waters, P., Fadda, G., Woodhall, M., O’Mahony, J., Brown, R.A. and Castro, D.A., et al. (2020) Serial Anti-Myelin Oligodendrocyte Glycoprotein Antibody Analyses and Outcomes in Children with Demyelinating Syndromes. JAMA Neurology, 77, 82-93. https://doi.org/10.1001/jamaneurol.2019.2940
|
[33]
|
Hino-Fukuyo, N., Haginoya, K., Takahashi, T., Nakashima, I., Fujihara, K., Takai, Y., et al. (2019) Long-Term Outcome of a Group of Japanese Children with Myelin-Oligodendrocyte Glycoprotein Encephalomyelitis without Preventive Immunosuppressive Therapy. Brain & Development, 41, 790-795. https://doi.org/10.1016/j.braindev.2019.06.004
|
[34]
|
Jarius, S., Ruprecht, K., Kleiter, I., Borisow, N., Asgari, N., Pitarokoili, K., et al. (2016) MOG-IgG in NMO and Related Disorders: A Multicenter Study of 50 patients. Part 2: Epidemiology, Clinical Presentation, Radiological and Laboratory Features, Treatment Responses, and Long-Term Outcome. Journal of Neuroinflammation, 13, Article No. 280.
https://doi.org/10.1186/s12974-016-0718-0
|
[35]
|
Pröbstel, A.K., Dornmair, K., Bittner, R., Sperl, P., Jenne, D., Magalhaes, S., et al. (2011) Antibodies to MOG Are Transient in Childhood Acute Disseminated Encephalomyelitis. Neurology, 77, 580-588.
https://doi.org/10.1212/WNL.0b013e318228c0b1
|
[36]
|
Huppke, P., Rostasy, K., Karenfort, M., Huppke, B., Seidl, R., Leiz, S., et al. (2013) Acute Disseminated Encephalomyelitis Followed by Recurrent or Monophasic Optic Neuritis in Pediatric Patients. Multiple Sclerosis Journal, 19, 941-946. https://doi.org/10.1177/1352458512466317
|